Pages that link to "Q40965602"

The following pages link to Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis (Q40965602):

Displaying 46 items.

• Circulating biomarkers to monitor cancer progression and treatment (Q26745985) (← links)
• miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition (Q28071987) (← links)
• Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma (Q33688925) (← links)
• MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. (Q33823829) (← links)
• The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model. (Q36323769) (← links)
• Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. (Q38842894) (← links)
• The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer (Q38902431) (← links)
• Recent progress toward the use of circulating microRNAs as clinical biomarkers (Q38944060) (← links)
• Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer (Q38987546) (← links)
• Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society. (Q39427143) (← links)
• Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence (Q40043175) (← links)
• Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer (Q40579865) (← links)
• Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. (Q40977712) (← links)
• Genome-wide miRNA response to anacardic acid in breast cancer cells (Q41491494) (← links)
• Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study (Q41991354) (← links)
• The miR-200 family in ovarian cancer. (Q42371676) (← links)
• The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis (Q47104938) (← links)
• Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas (Q47113981) (← links)
• Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer? (Q47150180) (← links)
• Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma (Q47271790) (← links)
• A new method to study the change of miRNA-mRNA interactions due to environmental exposures (Q47322221) (← links)
• The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma. (Q47831650) (← links)
• MicroRNAs in Cancer: challenges and opportunities in early detection, disease monitoring, and therapeutic agents (Q47920632) (← links)
• MicroRNAs as biomarkers for clinical studies (Q47947610) (← links)
• Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer (Q48230033) (← links)
• MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. (Q52725260) (← links)
• Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. (Q53689677) (← links)
• Differentially expressed circulating microRNAs in the development of acute diabetic Charcot foot (Q57673135) (← links)
• Aberrant miRNAs expressed in HER-2 negative breast cancers patient (Q57808476) (← links)
• The Significance Role of microRNA-200c as a Prognostic Factor in Various Human Solid Malignant Neoplasms: A Meta-Analysis (Q60922973) (← links)
• Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β-catenin signaling pathway via downregulating maternally expressed gene-3 (Q60931541) (← links)
• Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication (Q60958994) (← links)
• Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data (Q60961448) (← links)
• MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1 (Q61799147) (← links)
• Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer (Q64235739) (← links)
• Towards a more precise and individualized assessment of breast cancer risk (Q64240122) (← links)
• Plasma-based microRNA signatures in early diagnosis of breast cancer (Q89988188) (← links)
• A five-miRNA panel in plasma was identified for breast cancer diagnosis (Q90376964) (← links)
• Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma (Q90721521) (← links)
• Tumor-Derived Exosomes Mediate the Instability of Cadherins and Promote Tumor Progression (Q92256619) (← links)
• Prognostic role of microRNAs in breast cancer: A systematic review (Q92424275) (← links)
• miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells (Q92557230) (← links)
• Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management (Q92755500) (← links)
• Down-regulation of MiR-365 as a novel indicator to assess the progression and metastasis of hepatocellular carcinoma (Q92840469) (← links)
• Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability (Q92917120) (← links)
• Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers (Q94940502) (← links)